91 related articles for article (PubMed ID: 3479242)
21. Interaction among the distinct effects of adenine and guanine depletion in mouse lymphoma cells.
Nguyen BT; El Sayed YM; Sadée W
Cancer Res; 1984 Jun; 44(6):2272-7. PubMed ID: 6722768
[TBL] [Abstract][Full Text] [Related]
22. Conversion of 5'-deoxy-5'-methylthioadenosine and 5'-deoxy-5'-methylthioinosine to methionine in cultured human leukemic cells.
Savarese TM; Ghoda LY; Dexter DL; Parks RE
Cancer Res; 1983 Oct; 43(10):4699-702. PubMed ID: 6411330
[TBL] [Abstract][Full Text] [Related]
23. Characterization of mononuclear blood cell-derived differentiation inducing factors for the human promyelocytic leukemia cell line HL-60.
Olsson I; Olofsson T; Mauritzon N
J Natl Cancer Inst; 1981 Dec; 67(6):1225-30. PubMed ID: 6975849
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
25. Cytological effects of sulfur and selenium purine analogues on two transplantable hepatomas and on normal renewing cells in mice.
Melvin JB; Haight TH; Leduc EH
Cancer Res; 1984 Jul; 44(7):2794-8. PubMed ID: 6722809
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of HL-60 promyelocytic leukemia cells monitored by flow cytometric measurement of nitro blue tetrazolium (NBT) reduction.
Blair OC; Carbone R; Sartorelli AC
Cytometry; 1985 Jan; 6(1):54-61. PubMed ID: 3855396
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of sterol and phospholipid synthesis in HL-60 promyelocytic leukemia cells by inducers of myeloid differentiation.
Cooper RA; Ip SH; Cassileth PA; Kuo AL
Cancer Res; 1981 May; 41(5):1847-52. PubMed ID: 6938303
[TBL] [Abstract][Full Text] [Related]
28. Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation.
Chen SF; Cleaveland JS; Hollmann AB; Wiemann MC; Parks RE; Stoeckler JD
Cancer Res; 1986 Jul; 46(7):3449-55. PubMed ID: 3486711
[TBL] [Abstract][Full Text] [Related]
29. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.
Fibach E; Treves A; Kidron M; Mayer M
J Cell Physiol; 1985 May; 123(2):228-34. PubMed ID: 3884635
[TBL] [Abstract][Full Text] [Related]
30. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D
Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752
[TBL] [Abstract][Full Text] [Related]
31. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
Cheng HW; Armstrong RD; Sadée W
Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
[TBL] [Abstract][Full Text] [Related]
32. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
Matsui T; Nakao Y; Kobayashi N; Koizumi T; Nakagawa T; Kishihara M; Fujita T
Cancer Res; 1985 Jan; 45(1):311-6. PubMed ID: 3855282
[TBL] [Abstract][Full Text] [Related]
33. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation.
Tsiftsoglou AS; Wong W; Hyman R; Minden M; Robinson SH
Cancer Res; 1985 May; 45(5):2334-9. PubMed ID: 3857118
[TBL] [Abstract][Full Text] [Related]
34. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
35. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
Morin MJ; Sartorelli AC
Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
[TBL] [Abstract][Full Text] [Related]
37. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
38. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
39. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.
Jiang H; Lin J; Su ZZ; Collart FR; Huberman E; Fisher PB
Oncogene; 1994 Nov; 9(11):3397-406. PubMed ID: 7936668
[TBL] [Abstract][Full Text] [Related]
40. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H
Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
